Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.47 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.47 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.47 |
| ▸ | TNNI3K | Q59H18 | 15/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.42 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.42 |
| ▸ | ABL1 | P00519 | 2/20 | 0.41 |
| ▸ | BCR | P11274 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2226109 | 0.90 | CDK1 (0.44) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2225764 | 0.88 | CDK1 (0.38) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2227638 | 0.87 | TNNI3K (0.57) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2228424 | 0.83 | TNNI3K (0.61) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2225574 | 0.82 | TNNI3K (0.59) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2224948 | 0.82 | TNNI3K (0.51) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2227374 | 0.80 | CDK1 (0.51) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2227311 | 0.79 | TNNI3K (0.61) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| Trifluoroacetic Acid SCHEMBL2225019 | 0.79 | TNNI3K (0.44) | CDK1CCNB1CCNA2CCNE1CDK2 | |
| SCHEMBL2226458 | 0.79 | TNNI3K (0.49) | CDK1CCNB1CCNA2CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523559-A1 | COMPOUNDS AND METHODS | GlaxoSmithKline LLC (US) | 2012-11-21 | — | — | EP | claimed |
| WO-2011088027-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2011-07-21 | — | — | WO | claimed |
| EP-2523559-A1 | COMPOUNDS AND METHODS | GlaxoSmithKline LLC (US) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011088027-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2011-07-21 | — | — | WO | disclosed |